Got $5,000? 3 Stocks to Hold for the Next 20 Years

Long-term investors can consider buying shares of Dollarama and Curaleaf to generate market-beating gains in the next two decades.

| More on:
data analytics, chart and graph icons with female hands typing on laptop in background

Image source: Getty Images

It’s imperative for stock market investors to have a long-term view of equities, given the S&P 500 has returned 10% annually in the last five decades. So, you need to identify companies that have the potential to grow your wealth over time. These companies should ideally enjoy a wide economic moat and be part of rapidly expanding addressable markets to consistently outpace the broader market.

Here I have identified three such stocks Canadians can buy and hold for the next 20 years.

Brookfield Renewable Partners

One of the largest companies in the renewable energy space, Brookfield Renewable Partners (TSX:BEP.UN)(NYSE:BEP) operates 21 gigawatts (GWs) of clean energy assets. These assets consist of wind, hydro, and solar energy. It has a development pipeline of 69 GWs of projects, allowing BEP to triple its existing portfolio in the process.

To achieve its portfolio expansion goals, Brookfield Renewable is likely to deploy over US$1 billion in capital expenditures in the next five years.

The shift towards clean energy solutions globally is inevitable, and Brookfield Renewable is well positioned to take advantage of this secular tailwind.

Brookfield Renewable also offers investors a tasty dividend yield of 3.4%, and these payouts have increased at an annual rate of 6% since 2013. While the stock is trading 16% below all-time highs, Brookfield Renewable has returned close to 480% to investors in dividend-adjusted gains since August 2012.

Curaleaf

Investors bullish on the cannabis sector in the U.S. can consider buying shares of Curaleaf (CNSX:CURA), one of the largest marijuana producers in the world. Valued at a market cap of $5.9 billion, Curaleaf is also trading 77% below all-time highs.

The cannabis heavyweight increased sales from US$77 million in 2018 to US$1.21 billion in 2021, driven by the recent wave of legalization south of the border. In the second quarter (Q2), Curaleaf increased sales by 8% year over year to US$338 million compared to the 20% growth experienced in the March quarter.

Its adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) rose 18% to US$86 million, allowing Curaleaf to generate US$12 million in operating cash flow in Q2.

In the first six months of 2022, Curaleaf opened 28 new stores, taking its total count to 145 stores in the United States. Curaleaf’s acquisition of Bloom provides it access to Arizona while it began recreational sales in New Jersey earlier this year. Both states are billion-dollar markets and will be key drivers of revenue growth for Curaleaf in the next decade.

Dollarama

One of the top-performing TSX stocks, shares of Dollarama (TSX:DOL) have gained 758% since August 2012, easily crushing the broader markets. Shares of the discount retailer have surged 40% year to date, as consumer spending shifts towards consumer staple goods amid high inflation rates.

With 1,421 outlets, Dollarama is Canada’s largest discount retailer and benefits from its wide portfolio of low-cost products. Rising commodity prices and higher interest rates have reduced discretionary spending levels in Canada, spiking demand for Dollarama’s products.

Due to its market-thumping gains, Dollarama stock is valued at 30.8 times forward earnings, which is quite steep. But the company is also forecast to increase earnings at an annual rate of 16% in the next five years.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has positions in Brookfield Renewable Partners. The Motley Fool has no position in any of the stocks mentioned.

More on Cannabis Stocks

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Corp: Will it Ever Be a Buy?

Canopy Growth Corp (TSX:WEED) keeps going lower. Will it ever find a bottom?

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks a Good Buy in November 2023?

Cannabis stocks have slumped a long way down in the last few years, so is November the time to get…

Read more »

A cannabis plant grows.
Cannabis Stocks

2 Top Cannabis Stocks to Buy on the TSX Today

Two cannabis stocks are the top picks as the market moves toward consolidation and stability.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

2 Great Cannabis Stocks for New Investors

Quality cannabis companies such as Green Thumb can help long-term investors deliver outsized gains in the upcoming decade.

Read more »

A cannabis plant grows.
Cannabis Stocks

Will Canopy Growth Stock Pass $1 in November 2023?

Canopy Growth (TSX:WEED) stock needs to make some major changes if it hopes to get buyers back on board, and…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Canopy Growth Stock a Buy, Sell, or Hold Right Now?

Shares of Canopy Growth are trading 99% below all-time highs. Here's why WEED stock remains a high risk bet, despite…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

What’s Happening With Cannabis Stocks in November 2023?

Cannabis stocks have come a long way in the last five years -- they've dropped a long way. What can…

Read more »

Caution, careful
Cannabis Stocks

Buyer Beware: Canopy Growth Stock Is at Risk of a Bigger Drop

Canopy Growth Corp (TSX:WEED) stock has given investors a rough ride. Here's why it could get worse.

Read more »